Systematic Review : Cost-Effectiveness Analysis of Artificial Intelligence in Cancer Treatment
Indonesian Journal of Pharmacy · 02.03.2026 · 18-33
DOI: 10.22146/ijp.16226 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Indonesian Journal of Pharmacy, online erschienen am 02.03.2026. Verfasst von Ageng Aji Milendi und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0).
Abstract (Originalsprache)
Cancer is one of the leading causes of death and is estimated to cause huge global economic losses. Artificial intelligence (AI) has massively assisted in the diagnosis, prognosis, and determination of the most effective therapy for cancer patients. The utilization of AI is estimated to reduce healthcare expenditures. This study aimed to systematically review the implementation of AI and its cost-effectiveness in cancer treatment. The study followed PRISMA guidelines and utilized the PubMed database. The search strategy was conducted up to 2 September 2023 using three main keywords; “Cost-effectiveness analysis”, “Cancer”, and “Artificial intelligence”. From 1746 retrieved articles, a total of 11 articles were included in the analysis. Studies found two types of AI interventions in cancer; screening type intervention(n = 6; 55%) and surgery type (n = 5; 45%). Prostate cancer was the most frequently studied (n = 3; 27%). The cost-effectiveness analysis showed that the implementation of AI was cost-effective (n=5, 46%), particularly in cancer screening intervention. The review highlights two main groups of AI interventions in cancer care: screening and cancer surgery. From a cost-effectiveness point of view, AI intervention in screening was the most cost-effective strategy in cancer. On the other hand, the AI implementation in surgery showed inconsistent findings, with many studies not fully addressing the full economic evaluation.
Zitieren
APA
Milendi, A. A., Ulfa, E. U., Melgo, M. N. B., & Machlaurin, A. (2026). Systematic Review : Cost-Effectiveness Analysis of Artificial Intelligence in Cancer Treatment. Indonesian Journal of Pharmacy, 18-33. https://doi.org/10.22146/ijp.16226
Vancouver
Milendi AA, Ulfa EU, Melgo MNB, Machlaurin A. Systematic Review : Cost-Effectiveness Analysis of Artificial Intelligence in Cancer Treatment. Indonesian Journal of Pharmacy. 2026:18-33. doi:10.22146/ijp.16226
BibTeX
@article{Milendi2026,
author = {Milendi, Ageng Aji and Ulfa, Evi Umayah and Melgo, Mark Niño B. and Machlaurin, Afifah},
title = {Systematic Review : Cost-Effectiveness Analysis of Artificial Intelligence in Cancer Treatment},
journal = {Indonesian Journal of Pharmacy},
year = {2026},
pages = {18--33},
doi = {10.22146/ijp.16226}
}
EUVIMED